article thumbnail

PharmaShots Weekly Snapshot (August 20-24, 2018)

PharmaShots

Eisai's and Merck Announces EU's Marketing Approval of Lenvima (lenvatinib mesylate) for Hepatocellular Carcinoma Published: 23 Aug,2018 | Tags: Eisai, Merck, Approval, Lenvima, HCC, 2. Pfizer to co-promote Exact Sciences Cologuard Published: 22 Aug,2018 | Tags: Exact, Pfizer, Agreement, Promote, Cologuard 7.

article thumbnail

Barcelona Live 2018

pharmaphorum

Barcelona Live 2018 Mike.Hammerton Mon, 07/08/2023 - 13:51 Bookmark this

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Curious 2018 Live

pharmaphorum

Curious 2018 Live Mike.Hammerton Mon, 07/08/2023 - 15:08 Bookmark this

52
article thumbnail

Frontiers Health 2018 Live

pharmaphorum

Frontiers Health 2018 Live Mike.Hammerton Mon, 07/08/2023 - 15:23 Bookmark this

52
article thumbnail

Code of Ethics for Pharmacists 2018

RX Note

Malaysia Code of Ethics for Pharmacists 2018 has embodied minimum standards of proper conduct and professionalism for guidance of pharmacists in Malaysia. NOTE: Once, someone told me, the 7 principles in Code of Ethics For Pharmacists 2018 are very fairly similar to Code of Ethics for Pharmacists and Pharmacy Technician 2007 in UK.

article thumbnail

STAT+: The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat

STAT

Then, in 2018, she finally found a drug that kept her ADHD in check.  STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years.   Continue to STAT+ to read the full story…

article thumbnail

The XBI biotech index hit its lowest point since 2018. No one knows what comes next.

STAT

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology. Read the rest…